Drug therapy - Treatment of breast cancer

被引：586

作者：

Hortobagyi, GN ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Cancer Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1056/NEJM199810013391407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：974 / 984

页数：11

共 117 条

[1] ABE O, 1992, LANCET, V339, P71
[2] ABE O, 1995, NEW ENGL J MED, V333, P1444
[3] Abe O, 1996, NEW ENGL J MED, V334, P1003
[4] CHEMOTHERAPY AND SURVIVAL IN ADVANCED BREAST-CANCER - THE INCLUSION OF DOXORUBICIN IN COOPER TYPE REGIMENS
AHERN, RP
SMITH, IE
EBBS, SR
[J]. BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 801 - 805
[5] ANDERSON DE, 1992, CANCER-AM CANCER SOC, V70, P1740, DOI 10.1002/1097-0142(19920915)70:4+<1740::AID-CNCR2820701615>3.0.CO
[6] 2-1
[7] [Anonymous], 1996, Lancet, V348, P1189
[8] High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
Antman, KH
Rowlings, PA
Vaughan, WP
Pelz, CJ
Fay, JW
Fields, KK
Freytes, CO
Gale, RP
Hillner, BE
Holland, HK
Kennedy, MJ
Klein, JP
Lazarus, HM
McCarthy, PL
Saez, R
Spitzer, G
Stadtmauer, EA
Williams, SF
Wolff, S
Sobocinski, KA
Armitage, JO
Horowitz, MM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1870 - 1879
[9] Ballo MS, 1996, CANCER, V78, P773
[10] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast
Baselga, J
Tripathy, D
Mendelsohn, J
Baughman, S
Benz, CC
Dantis, L
Sklarin, NT
Seidman, AD
Hudis, CA
Moore, J
Rosen, PP
Twaddell, T
Henderson, IC
Norton, L
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 737 - 744